The largest database of trusted experimental protocols

7 protocols using uvi3003

1

Metamorphosis Regulation in Marine Invertebrates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fertilized eggs were reared in petri dishes with sea water at room temperature. The untreated embryos were collected and divided into several groups for experiments. Each group included 200 embryos. The treatment groups received MMI (Sigma; 301507, 1 g/L), BMS493 (Sigma; B6688, 1 μm), and UVI3003 (Sigma; SML1950, 1 μm), respectively, at the hatched swimming larval stage (15 hpf), while the control group received either the filtered fresh sea water (control for MMI) or DMSO (control for BMS493 and UVI3003) at the same developmental stage. For the dexamethasone (complement inhibitor) treatment experiments, the fertilized eggs were treated with 10 and 20 µm methanol (control) or dexamethasone (Sigma; D1756, 10 μm), respectively. The number of metamorphic juveniles and total embryos were counted at 22 hpf. The experiments were repeated three times, and the analysis of significant differences in the statistical data was performed on SPSS 17.0 via the chi‐squared test. p value <.01.
+ Open protocol
+ Expand
2

Retinoid Receptor Agonists and Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATRA, RARα agonist BMS753, RARα antagonist BMS195614, retinoid X receptor (RXR) α agonist LG100268, and pan RXR antagonist UVI3003 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibiotic-antimycotic, HEPES (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid) buffer, and β-mercaptoethanol were purchased from Invitrogen Corp (Gibco BRL, MD, USA).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant interleukins (ILs) were purchased from PeproTec (London, UK), except for human IL-2 (Shionogi, Osaka, Japan). All retinoids (all-trans form), LE540, and UVI3003 were purchased from Sigma-Aldrich (St. Louis, MO, USA), Wako (Osaka, Japan), and Tocris Bioscience (Ellisville, MO, USA), respectively. All antibodies used in this study are listed in Supplementary Table 4. Cells were incubated with FcR blocking Reagent (Miltenyi Biotec) and then stained with the appropriate combinations of mAbs and fluorochrome-conjugated streptavidin. For intracellular cytokine staining, cells were incubated with or without SIINFEKL peptide (1 μM) or PMA + ionomycin in the presence of brefeldin A for 4 h and stained using the Cytofix/Cytoperm Kit (BD Bioscience, Franklin Lakes, NJ, USA). Foxp3-positive cells and apoptotic cells were detected using the BD Foxp3 Staining Kit (BD Bioscience) and Apoptosis Detection Kit (BD Bioscience), respectively. For cell surface-stained samples, 7-aminoactinomycin D (7AAD; eBioscience) was added just before the flow cytometric analysis to exclude dead cells. Flow cytometry was performed using FACSAria. The data were analyzed using FlowJo software (TreeStar, San Carlos, CA, USA).
+ Open protocol
+ Expand
4

Retinoid Receptor Ligand Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ligands ATRA, 9cRA, 13cRA, BMS493 (an RAR antagonist), BMS649 (an RXR agonist), and UVI3003 (an RXR antagonist) were purchased from Sigma-Aldrich. Stock solutions of the different compounds were prepared in ethanol at 10 mM.
+ Open protocol
+ Expand
5

Bexarotene Attenuates SAH Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bexarotene (Selleck Chemicals, Houston, USA) was diluted in 10% dimethyl sulfoxide (DMSO). Administered 1 h after SAH by i.p injection, three different doses (5 mg/kg, 15 mg/kg, and 45 mg/kg) were evaluated. The SAH + vehicle group received an equal volume of 10% DMSO. The RXR inhibitor UVI3003 (75 μg/rat, Sigma-Aldrich, St. Louis, MO) or selective SIRT6 antagonist OSS128167 (100 μg/rat, Selleck Chemicals, Houston, TX) dissolved in 10% DMSO was injected by i.c.v route at 1 h before SAH. The same volume of 10% DMSO was injected via i.c.v in SAH + Bexa + vehicle group.
+ Open protocol
+ Expand
6

Adipogenic Differentiation Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alitretinoin was bought from Santa Cruz Biotechnology (Santa Cruz, CA). Bexarotene and heparin sodium were purchased from Selleck Chemicals (Houston, TX, USA). UVI3003, dexamethasone (DEX), 3-isobutyl-1-methylxanthine (IBMX), and insulin were obtained from Sigma Company (Sigma-Aldrich, St. Louis, MO, USA).
+ Open protocol
+ Expand
7

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant interleukins (ILs) were purchased from PeproTec (London, UK), except for human IL-2 (Shionogi, Osaka, Japan). All retinoids (all-trans form), LE540, and UVI3003 were purchased from Sigma-Aldrich (St. Louis, MO, USA), Wako (Osaka, Japan), and Tocris Bioscience (Ellisville, MO, USA), respectively. All antibodies used in this study are listed in Supplementary Table 4. Cells were incubated with FcR blocking Reagent (Miltenyi Biotec) and then stained with the appropriate combinations of mAbs and fluorochrome-conjugated streptavidin.
For intracellular cytokine staining, cells were incubated with or without SIINFEKL peptide (1 μM) or PMA + ionomycin in the presence of brefeldin A for 4 h and stained using the Cytofix/Cytoperm Kit (BD Bioscience, Franklin Lakes, NJ, USA). Foxp3-positive cells and apoptotic cells were detected using the BD Foxp3 Staining Kit (BD Bioscience) and Apoptosis Detection Kit (BD Bioscience), respectively. For cell surface-stained samples, 7-aminoactinomycin D (7AAD; eBioscience) was added just before the flow cytometric analysis to exclude dead cells. Flow cytometry was performed using FACSAria. The data were analyzed using FlowJo software (TreeStar, San Carlos, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!